Antihyperlipidemic Effects of Rhapontin and Rhapontigenin from Rheum undulatum in Rats Fed a High-Cholesterol Diet

Sung Pil Jo, Jeong Keun Kim, Young Hee Lim

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Rhapontin was purified from a methanol extract from the roots of Rheum undulatum, and rhapontigenin was produced by an enzymatic transformation of rhapontin. Rats were fed a high-cholesterol diet to induce hyperlipidemia, followed by oral treatment with rhapontin or rhapontigenin (1-5mg/kg/day). Rhapontin and rhapontigenin treatment resulted in a significant (p<0.05) dose-dependent decrease in the serum lipid level, while the high-density lipoprotein cholesterol level increased slightly compared with the experimental control. Furthermore, rhapontin and rhapontigenin treatment improved the pathological characteristics of the degenerating fatty liver in high-cholesterol diet-induced hyperlipidemic rats dose-dependently. Aspartate aminotransferase and alanine aminotransferase levels in rhapontin- and rhapontigenin-treated hyperlipidemic rats were not significantly different from those in the control. These results indicate that rhapontin and rhapontigenin can be used as potent antihyperlipidemic agents.

Original languageEnglish
Pages (from-to)1067-1071
Number of pages5
JournalPlanta Medica
Volume80
Issue number13
DOIs
Publication statusPublished - 2014 Aug 1

Fingerprint

Rheum
Hypolipidemic Agents
Nutrition
Rats
Cholesterol
Diet
Fatty Liver
Aspartate Aminotransferases
rhapontigenin
rhapontin
Hyperlipidemias
Alanine Transaminase
Liver
HDL Cholesterol
Methanol
Lipids
Serum

Keywords

  • antihyperlipidemic effect
  • high-cholesterol diet
  • methoxylated stilbene
  • Polygonaceae
  • Rheum undulatum

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Pharmaceutical Science
  • Analytical Chemistry
  • Organic Chemistry
  • Molecular Medicine
  • Complementary and alternative medicine
  • Medicine(all)

Cite this

Antihyperlipidemic Effects of Rhapontin and Rhapontigenin from Rheum undulatum in Rats Fed a High-Cholesterol Diet. / Jo, Sung Pil; Kim, Jeong Keun; Lim, Young Hee.

In: Planta Medica, Vol. 80, No. 13, 01.08.2014, p. 1067-1071.

Research output: Contribution to journalArticle

@article{a4a7ea88750049dfb414a4f18d67d6f0,
title = "Antihyperlipidemic Effects of Rhapontin and Rhapontigenin from Rheum undulatum in Rats Fed a High-Cholesterol Diet",
abstract = "Rhapontin was purified from a methanol extract from the roots of Rheum undulatum, and rhapontigenin was produced by an enzymatic transformation of rhapontin. Rats were fed a high-cholesterol diet to induce hyperlipidemia, followed by oral treatment with rhapontin or rhapontigenin (1-5mg/kg/day). Rhapontin and rhapontigenin treatment resulted in a significant (p<0.05) dose-dependent decrease in the serum lipid level, while the high-density lipoprotein cholesterol level increased slightly compared with the experimental control. Furthermore, rhapontin and rhapontigenin treatment improved the pathological characteristics of the degenerating fatty liver in high-cholesterol diet-induced hyperlipidemic rats dose-dependently. Aspartate aminotransferase and alanine aminotransferase levels in rhapontin- and rhapontigenin-treated hyperlipidemic rats were not significantly different from those in the control. These results indicate that rhapontin and rhapontigenin can be used as potent antihyperlipidemic agents.",
keywords = "antihyperlipidemic effect, high-cholesterol diet, methoxylated stilbene, Polygonaceae, Rheum undulatum",
author = "Jo, {Sung Pil} and Kim, {Jeong Keun} and Lim, {Young Hee}",
year = "2014",
month = "8",
day = "1",
doi = "10.1055/s-0034-1382999",
language = "English",
volume = "80",
pages = "1067--1071",
journal = "Planta Medica",
issn = "0032-0943",
publisher = "Georg Thieme Verlag",
number = "13",

}

TY - JOUR

T1 - Antihyperlipidemic Effects of Rhapontin and Rhapontigenin from Rheum undulatum in Rats Fed a High-Cholesterol Diet

AU - Jo, Sung Pil

AU - Kim, Jeong Keun

AU - Lim, Young Hee

PY - 2014/8/1

Y1 - 2014/8/1

N2 - Rhapontin was purified from a methanol extract from the roots of Rheum undulatum, and rhapontigenin was produced by an enzymatic transformation of rhapontin. Rats were fed a high-cholesterol diet to induce hyperlipidemia, followed by oral treatment with rhapontin or rhapontigenin (1-5mg/kg/day). Rhapontin and rhapontigenin treatment resulted in a significant (p<0.05) dose-dependent decrease in the serum lipid level, while the high-density lipoprotein cholesterol level increased slightly compared with the experimental control. Furthermore, rhapontin and rhapontigenin treatment improved the pathological characteristics of the degenerating fatty liver in high-cholesterol diet-induced hyperlipidemic rats dose-dependently. Aspartate aminotransferase and alanine aminotransferase levels in rhapontin- and rhapontigenin-treated hyperlipidemic rats were not significantly different from those in the control. These results indicate that rhapontin and rhapontigenin can be used as potent antihyperlipidemic agents.

AB - Rhapontin was purified from a methanol extract from the roots of Rheum undulatum, and rhapontigenin was produced by an enzymatic transformation of rhapontin. Rats were fed a high-cholesterol diet to induce hyperlipidemia, followed by oral treatment with rhapontin or rhapontigenin (1-5mg/kg/day). Rhapontin and rhapontigenin treatment resulted in a significant (p<0.05) dose-dependent decrease in the serum lipid level, while the high-density lipoprotein cholesterol level increased slightly compared with the experimental control. Furthermore, rhapontin and rhapontigenin treatment improved the pathological characteristics of the degenerating fatty liver in high-cholesterol diet-induced hyperlipidemic rats dose-dependently. Aspartate aminotransferase and alanine aminotransferase levels in rhapontin- and rhapontigenin-treated hyperlipidemic rats were not significantly different from those in the control. These results indicate that rhapontin and rhapontigenin can be used as potent antihyperlipidemic agents.

KW - antihyperlipidemic effect

KW - high-cholesterol diet

KW - methoxylated stilbene

KW - Polygonaceae

KW - Rheum undulatum

UR - http://www.scopus.com/inward/record.url?scp=84930491198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930491198&partnerID=8YFLogxK

U2 - 10.1055/s-0034-1382999

DO - 10.1055/s-0034-1382999

M3 - Article

C2 - 25127020

AN - SCOPUS:84930491198

VL - 80

SP - 1067

EP - 1071

JO - Planta Medica

JF - Planta Medica

SN - 0032-0943

IS - 13

ER -